Skip to content

Clinical trials

Completed Prostatic Neoplasms trials in Norway

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Neoplasms Status: Completed Country / region: Norway Clear all

42 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20023
20031
20042
20061
20071
20083
20093
20102
20113
20121
20132
20143
20152
20161
20173
20191
20202
20214
20221
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed42

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Oslo University Hospital12
AstraZeneca3
Bayer3
Ferring Pharmaceuticals3
Norwegian University of Science and Technology3
Bristol-Myers Squibb2
Sykehuset Innlandet HF2
Ultimovacs ASA2
Alden Cancer Therapy II1
Astellas Pharma Europe Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Neoplasms42
Neoplasms5
Breast Neoplasms3
Neoplasm Metastasis2
Bone Diseases1
Bone Neoplasms1
Colorectal Neoplasms1
Lymphoma1
Neoplasm Recurrence, Local1
Rectal Neoplasms1

Trials

Showing 1 to 25 of 42. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.